Literature DB >> 29637270

Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.

Audrey Letourneau1, Marie Maerevoet2, Dina Milowich1, Roland Dewind3, Bettina Bisig1, Edoardo Missiaglia1, Laurence de Leval4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29637270     DOI： 10.1007/s00428-018-2352-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  14 in total

1.  Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.

Authors:  Melissa G Lechner; Stephen Lade; Daniel J Liebertz; H Miles Prince; Garry S Brody; Howard R Webster; Alan L Epstein
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia.

Authors:  D Bellanger; V Jacquemin; M Chopin; G Pierron; O A Bernard; J Ghysdael; M-H Stern
Journal:  Leukemia       Date:  2013-09-19       Impact factor: 11.528

4.  Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.

Authors:  Arianna Di Napoli; Preti Jain; Enrico Duranti; Elizabeth Margolskee; Walter Arancio; Fabio Facchetti; Bachir Alobeid; Fabio Santanelli di Pompeo; Mahesh Mansukhani; Govind Bhagat
Journal:  Br J Haematol       Date:  2016-11-10       Impact factor: 6.998

Review 5.  Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

Authors:  Thomas A Waldmann; Jing Chen
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

6.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

7.  Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Authors:  Piers Blombery; Ella R Thompson; Kate Jones; Gisela Mir Arnau; Stephen Lade; John F Markham; Jason Li; Anand Deva; Ricky W Johnstone; Amit Khot; H Miles Prince; David Westerman
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

8.  The Genetic Basis of Hepatosplenic T-cell Lymphoma.

Authors:  Matthew McKinney; Andrea B Moffitt; Philippe Gaulard; Marion Travert; Laurence De Leval; Alina Nicolae; Mark Raffeld; Elaine S Jaffe; Stefania Pittaluga; Liqiang Xi; Tayla Heavican; Javeed Iqbal; Karim Belhadj; Marie Helene Delfau-Larue; Virginie Fataccioli; Magdalena B Czader; Izidore S Lossos; Jennifer R Chapman-Fredricks; Kristy L Richards; Yuri Fedoriw; Sarah L Ondrejka; Eric D Hsi; Lawrence Low; Dennis Weisenburger; Wing C Chan; Neha Mehta-Shah; Steven Horwitz; Leon Bernal-Mizrachi; Christopher R Flowers; Anne W Beaven; Mayur Parihar; Lucile Baseggio; Marie Parrens; Anne Moreau; Pierre Sujobert; Monika Pilichowska; Andrew M Evens; Amy Chadburn; Rex K H Au-Yeung; Gopesh Srivastava; William W L Choi; John R Goodlad; Igor Aurer; Sandra Basic-Kinda; Randy D Gascoyne; Nicholas S Davis; Guojie Li; Jenny Zhang; Deepthi Rajagopalan; Anupama Reddy; Cassandra Love; Shawn Levy; Yuan Zhuang; Jyotishka Datta; David B Dunson; Sandeep S Davé
Journal:  Cancer Discov       Date:  2017-01-25       Impact factor: 39.397

9.  Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma.

Authors:  Melissa G Lechner; Carolina Megiel; Connor H Church; Trevor E Angell; Sarah M Russell; Rikki B Sevell; Julie K Jang; Garry S Brody; Alan L Epstein
Journal:  Clin Cancer Res       Date:  2012-07-12       Impact factor: 12.531

10.  JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations.

Authors:  Yuan Ren; Yonghong Zhang; Richard Z Liu; David A Fenstermacher; Kenneth L Wright; Jamie K Teer; Jie Wu
Journal:  Sci Rep       Date:  2013-10-24       Impact factor: 4.379
View more
  14 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Authors:  Camille Laurent; Alina Nicolae; Cécile Laurent; Fabien Le Bras; Corinne Haioun; Virginie Fataccioli; Nadia Amara; José Adélaïde; Arnaud Guille; Jean-Marc Schiano; Bruno Tesson; Alexandra Traverse-Glehen; Marie-Pierre Chenard; Lénaïg Mescam; Anne Moreau; Catherine Chassagne-Clement; Joan Somja; Frédéric Escudié; Marc André; Nadine Martin; Laetitia Lacroix; François Lemonnier; Anne-Sophie Hamy; Fabien Reyal; Marie Bannier; Lucie Oberic; Nais Prade; François-Xavier Frénois; Asma Beldi-Ferchiou; Marie-Helene Delfau-Larue; Reda Bouabdallah; Daniel Birnbaum; Pierre Brousset; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2020-01-30       Impact factor: 22.113

Review 3.  Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Mark W Clemens; Ryan C DeCoster; Berry Fairchild; Alexander A Bessonov; Fabio Santanelli di Pompeo
Journal:  Semin Plast Surg       Date:  2019-10-17       Impact factor: 2.314

Review 4.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 5.  Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  P Rastogi; A K Deva; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

6.  Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Authors:  Elaine S Jaffe; Binita S Ashar; Mark W Clemens; Andrew L Feldman; Philippe Gaulard; Roberto N Miranda; Aliyah R Sohani; Timothy Stenzel; Sung W Yoon
Journal:  J Clin Oncol       Date:  2020-02-11       Impact factor: 44.544

7.  Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.

Authors:  Andrés E Quesada; Yanming Zhang; Ryan Ptashkin; Caleb Ho; Steven Horwitz; Ryma Benayed; Ahmet Dogan; Maria E Arcila
Journal:  Breast J       Date:  2021-02-18       Impact factor: 2.431

8.  A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Paul Zumbo; Jude M Phillips; Zhaoqi Liu; Shuhua Cheng; Liron Yoffe; Paola Ghione; Federica Di Maggio; Ahmet Dogan; Inna Khodos; Elisa de Stanchina; Joseph Casano; Clarisse Kayembe; Wayne Tam; Doron Betel; Robin Foa'; Leandro Cerchietti; Raul Rabadan; Steven Horwitz; David M Weinstock; Giorgio Inghirami
Journal:  Cancers (Basel)       Date:  2020-06-17       Impact factor: 6.639

9.  Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.

Authors:  Piers Blombery; Ella Thompson; Georgina L Ryland; Rachel Joyce; David J Byrne; Christine Khoo; Stephen Lade; Mark Hertzberg; Greg Hapgood; Paula Marlton; Anand Deva; Geoffrey Lindeman; Stephen Fox; David Westerman; Miles Prince
Journal:  Oncotarget       Date:  2018-11-16

10.  UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group.

Authors:  Philip Turton; Dima El-Sharkawi; Iain Lyburn; Bhupinder Sharma; Preethika Mahalingam; Suzanne D Turner; Fiona MacNeill; Laura Johnson; Stephen Hamilton; Cathy Burton; Nigel Mercer
Journal:  Br J Haematol       Date:  2020-11-22       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.